Exploring HIV infection and susceptibility to measles among older children and adults in Malawi: a facility-based study
Authors
Polonsky, Jonathan ASingh, Beverley
Masiku, Charlie
Langendorf, Céline
Kagoli, Matthew
Hurtado, Northan
Berthelot, Mathilde
Heinzelmann, Annette
Puren, Adrian
Grais, Rebecca F
Issue Date
2014-12-11
Metadata
Show full item recordAbstract
Background HIV infection increases measles susceptibility in infants, but little is known about this relationship among older children and adults. We conducted a facility-based study to explore whether HIV status and/or CD4 count were associated with either measles seroprotection and/or measles antibody concentration. Methods We conveniently sampled HIV-infected patients presenting for follow-up care, and HIV-uninfected individuals presenting for HIV testing at Chiradzulu District Hospital, Malawi, from January to September 2012. We recorded age, sex and reported measles vaccination and infection history. Blood samples were taken to determine CD4 count and measles antibody concentration. Results 1935 (1434 HIV-infected; 501 HIV-uninfected) participants were recruited. The majority of adults, and approximately half the children, were measles seroprotected, with lower odds among HIV-infected children (adjusted OR=0.27, 95% CI: 0.10-0.69, p=0.006), but not adults. Among HIV-infected participants, neither CD4 count (p=0.16) nor time on antiretroviral therapy (p=0.25) were associated with measles antibody concentration, while older age (p<0.001) and female sex (p<0.001) were independently associated with this measure. Conclusions We found no evidence that HIV infection contributes to the risk for measles infection among adults, but HIV-infected children (including at ages older than previously reported), were less likely to be seroprotected in this sample.Publisher
ElsevierPubMed ID
25499042Language
enISSN
1878-3511ae974a485f413a2113503eed53cd6c53
10.1016/j.ijid.2014.12.010
Scopus Count
Collections
Related articles
- Measles seroprevalence in Chiradzulu district, Malawi: Implications for evaluating vaccine coverage.
- Authors: Polonsky JA, Juan-Giner A, Hurtado N, Masiku C, Kagoli M, Grais RF
- Issue date: 2015 Aug 26
- Seroprevalence of measles vaccine antibody response in vertically HIV-infected children, in Morocco.
- Authors: Haban H, Benchekroun S, Sadeq M, Tajounte L, Ahmed HJ, Benjouad A, Amzazi S, Oumzil H, Elharti E
- Issue date: 2018 Dec 19
- Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.
- Authors: Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, Bolton-Moore C, Moss WJ
- Issue date: 2013 Dec 1
- Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults.
- Authors: Sha BE, Harris AA, Benson CA, Atkinson WL, Urbanski PA, Stewart JA, Williams WW, Murphy RL, Phair JP, Levin SA
- Issue date: 1991 Nov
- Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
- Authors: Helfand RF, Witte D, Fowlkes A, Garcia P, Yang C, Fudzulani R, Walls L, Bae S, Strebel P, Broadhead R, Bellini WJ, Cutts F
- Issue date: 2008 Nov 15